Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hapag-Lloyd to continue avoiding Suez canal until at least Jan 9

(Sharecast News) - German shipping company Hapag-Lloyd on Tuesday said it would continue to divert its vessels away from the Suez Canal/Red Sea to avoid attacks by Yemeni Houthi militants. Ships will continue to take the longer route via the Cape of Good Hope, adding to costs for customers and lengthening journeys.

"We monitor the situation closely day-by-day, but will continue to reroute our vessels until January 9," a spokesperson for the world's fifth biggest container liner told the Reuters wire agency.

The Houthi have been attacking ships in the region, claiming it is in response to Israel's bombardment and invasion of Gaza after members of the Hamas Islamic group killed more than 1,000 Israeli civilians in an assault on October 7.

One of Hapag-Lloyd's ships was attacked near Yemen on December 15, while a vessel owned by Danish rival Maersk was also fired upon on the weekend before US forces intervened and killed 10 militants.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Biome Technologies shares sink as Q1 sales drop 44%
(Sharecast News) - Shares in AIM-listed Biome Technologies plummeted by almost a third on Monday after the bioplastics and radio frequency technology business reported a poor start to the year with first-quarter sales dropping by 44%.
Entain reprices two term loans, revises interest cost outlook
(Sharecast News) - Betting and gambling giant Entain announced the successful repricing of two of its existing 'Term Loan B' loans on Monday, along with the pricing and allocation of fungible add-ons, in a bid to optimise its financial position.
Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.